Clinical TrialsSearch results
Number of results: 500
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- An Open-Label, Non-Randomized Study to Assess the Safety and Efficacy of Leniolisib in Japanese Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Followed By an Open-Label Long-Term Extension
- activated phosphoinositide 3-kinase delta syndrome (APDS)
- Bradt Jason
- 2023-07-04
Recruiting
- Grope of the promotion of appetite using Virtual Reality (VR)
- Loneliness
- Ishinaga Kojiro
- 2023-06-18
Recruiting
- Association between the palatability of the meal and the appetite
- anorexia
- Ishinaga Kojiro
- 2023-06-17
Other
- Microvessel detection test by photoacoustic imaging
- Lymphedema
- Koshima Isao
- 2023-06-02
Not yet recruiting
- The Effect of Food Variety on Oral Function and Mood State
- mood disorder
- Yoshizako Yu
- 2023-04-30
Recruiting
- Multicentre, open-label, dose-escalation phase I/II study to evaluate the tolerability, safety, efficacy and pharmacokinetics of repeated continuous intravenous PPMX-T003 in patients with aggressive NK cell leukaemia (ANKL) (physician-initiated clinical trial).
- Aggressive NK-cell Leukemia
- ando kiyoshi
- 2023-04-28
Recruiting
- iStent inject with cataract surgery for primary angle closure glaucoma
- Primary angle closure glaucoma
- Hirooka Kazuyuki
- 2023-04-24
Other
- An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II
- Hereditary Angioedema
- Smith Michael
- 2023-04-12
Completed
- Study on the efficacy and safety of lidocaine tape application as a surface anesthesia for the mucous membranes of the mouth
- Healthy volunteers
- Yanamoto Souichi
- 2023-04-11
Completed
- Study on the safety and nutritional status improvement of L-arginine hydrochloride intervention for ALS
- Amyotrophic lateral sclerosis
- Horofumi Maruyama
- 2023-04-11